Customer Spotlight: Ahold Delhaize

Learn how the Verve Motion SafeLiftTM exosuit transformed Ahold Delhaize’s Hannaford Distribution Center operations by drastically decreasing back and hip injuries, while boosting productivity and reducing worker fatigue, leading to a happier, healthier workforce. 


Download the case study by completing the form. 

Revolutionizing Safety & Efficiency In Modern Distribution Centers.

Faced with a growing number of strains and sprains, particularly among new hires, Ahold Delhaize, one of the world's largest food retail groups, was in search of a solution. Looking to reduce injuries, increase productivity, and stem turnover the company turned to Verve Motion and ourSafeLiftTM exosuit; a wearable robot that takes up to 40% of the strain off a worker's back with every lift. 

Download the case study to learn about the impact of the SafeLift exosuit on operations and safety at on Ahold's Hannaford distribution center in Schodack NY including:

  • Ahold's distribution center needs and the exosuit benefits (lower injury rates, facility productivity, warehouse worker safety)

  • Verve Motion’s  SafeLift exosuit deployment into Ahold's daily personal protective equipment (PPE) arsenal

  • Reduced fatigue, decreased downtime and absenteeism, which could ultimately translate into significant cost savings, and more!

 “The results experienced in this pilot study are proof that soft exosuits can enhance lives and help companies achieve critical productivity goals.”

-Ignacio Galiana, CEO and co-founder of Verve Motion

vlcsnap_x600

 

Download Case Study

About Verve Motion

VM CloseUp Suite Logo

Verve Motion's exosuit is helping to redefine industrial workplaces and worker safety.

Since 2020, Verve Motion and their wearable robotics technology has committed to improving the lives of workers across various industries, with a passion for innovation and focus on ergonomics, safety, and productivity. Spun out from Harvard University’s Biodesign Laboratory at the Wyss Institute, Verve Motion is based on a decade of research funded by the DARPA - military, National Science Foundation, and National Institutes of Health.